{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T12:37:11Z","timestamp":1721911031742},"reference-count":101,"publisher":"Elsevier","isbn-type":[{"value":"9780323328890","type":"print"}],"license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015]]},"DOI":"10.1016\/b978-0-323-32889-0.00016-9","type":"book-chapter","created":{"date-parts":[[2015,1,23]],"date-time":"2015-01-23T20:28:51Z","timestamp":1422044931000},"page":"263-287","source":"Crossref","is-referenced-by-count":3,"title":["Role of Nanogenotoxicology Studies in Safety Evaluation of Nanomaterials"],"prefix":"10.1016","author":[{"given":"Henriqueta","family":"Louro","sequence":"first","affiliation":[]},{"given":"Ana","family":"Bettencourt","sequence":"additional","affiliation":[]},{"given":"L\u00eddia M.","family":"Gon\u00e7alves","sequence":"additional","affiliation":[]},{"given":"Ant\u00f3nio J.","family":"Almeida","sequence":"additional","affiliation":[]},{"given":"Maria","family":"Jo\u00e3o Silva","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/B978-0-323-32889-0.00016-9_bib1","first-page":"38","article-title":"Commission Recommendation of 18 October 2011 on the definition of nanomaterial","volume":"L275","author":"European Comission","year":"2011","journal-title":"Official J Eur Union"},{"issue":"3","key":"10.1016\/B978-0-323-32889-0.00016-9_bib2","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1163\/156856207779996931","article-title":"Nanostructured materials for applications in drug delivery and tissue engineering","volume":"18","author":"Goldberg","year":"2007","journal-title":"J Biomater Sci Polym Ed"},{"issue":"12","key":"10.1016\/B978-0-323-32889-0.00016-9_bib3","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.addr.2009.07.008","article-title":"Electrospun materials as potential platforms for bone tissue engineering","volume":"61","author":"Jang","year":"2009","journal-title":"Adv Drug Deliv Rev"},{"issue":"7\u20138","key":"10.1016\/B978-0-323-32889-0.00016-9_bib4","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.addr.2010.02.002","article-title":"Nanomaterials for in situ cell delivery and tissue regeneration","volume":"62","author":"Wan","year":"2010","journal-title":"Adv Drug Deliv Rev"},{"issue":"5","key":"10.1016\/B978-0-323-32889-0.00016-9_bib5","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.biotechadv.2012.08.001","article-title":"Nanomaterial scaffolds for stem cell proliferation and differentiation in tissue engineering","volume":"31","author":"Zhao","year":"2013","journal-title":"Biotechnol Adv"},{"issue":"4\u20135","key":"10.1016\/B978-0-323-32889-0.00016-9_bib6","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.addr.2007.03.019","article-title":"Matrices and scaffolds for drug delivery in dental, oral and craniofacial tissue engineering","volume":"59","author":"Moioli","year":"2007","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/B978-0-323-32889-0.00016-9_bib7","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1477-3155-9-55","article-title":"Biodegradable nanoparticles are excellent vehicle for site directed in vivo delivery of drugs and vaccines","volume":"9","author":"Mahapatro","year":"2011","journal-title":"J Nanobiotechnol"},{"issue":"3","key":"10.1016\/B978-0-323-32889-0.00016-9_bib8","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3390\/polym3031377","article-title":"Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier","volume":"3","author":"Makadia","year":"2011","journal-title":"Polymers (Basel)"},{"issue":"3","key":"10.1016\/B978-0-323-32889-0.00016-9_bib9","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1098\/rsfs.2011.0123","article-title":"Poly(lactide-co-glycolide) porous scaffolds for tissue engineering and regenerative medicine","volume":"2","author":"Pan","year":"2012","journal-title":"Interface Focus"},{"issue":"4","key":"10.1016\/B978-0-323-32889-0.00016-9_bib10","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2217\/nnm.13.44","article-title":"Nanocomposites for bone tissue regeneration","volume":"8","author":"Sahoo","year":"2013","journal-title":"Nanomedicine"},{"issue":"47","key":"10.1016\/B978-0-323-32889-0.00016-9_bib11","doi-asserted-by":"crossref","first-page":"5835","DOI":"10.1039\/c2cc32149a","article-title":"Engineering of lipid-coated PLGA nanoparticles with a tunable payload of diagnostically active nanocrystals for medical imaging","volume":"48","author":"Mieszawska","year":"2012","journal-title":"Chem Commun (Camb)"},{"key":"10.1016\/B978-0-323-32889-0.00016-9_bib12","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.eurpolymj.2012.12.009","article-title":"Chitosan-based biomaterials for tissue engineering","volume":"49","author":"Croisier","year":"2013","journal-title":"Eur Polym J"},{"issue":"2","key":"10.1016\/B978-0-323-32889-0.00016-9_bib13","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.ejpb.2012.07.005","article-title":"Development of a novel mucosal vaccine against strangles by supercritical enhanced atomization spray-drying of Streptococcus equi extracts and evaluation in a mouse model","volume":"82","author":"Rodrigues","year":"2012","journal-title":"Eur J Pharm Biopharm"},{"issue":"4","key":"10.1016\/B978-0-323-32889-0.00016-9_bib14","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ejps.2011.09.018","article-title":"Development and characterization of a new plasmid delivery system based on chitosan-sodium deoxycholate nanoparticles","volume":"45","author":"Cadete","year":"2012","journal-title":"Eur J Pharm Sci"},{"issue":"2","key":"10.1016\/B978-0-323-32889-0.00016-9_bib15","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.jconrel.2012.03.017","article-title":"Chitosan-based drug nanocarriers: where do we stand?","volume":"161","author":"Garcia-Fuentes","year":"2012","journal-title":"J Control Release"},{"issue":"9","key":"10.1016\/B978-0-323-32889-0.00016-9_bib16","doi-asserted-by":"crossref","first-page":"8037","DOI":"10.1016\/j.actbio.2013.06.014","article-title":"Calcium phosphate ceramics in bone tissue engineering: a review of properties and their influence on cell behavior","volume":"9","author":"Samavedi","year":"2013","journal-title":"Acta Biomater"},{"key":"10.1016\/B978-0-323-32889-0.00016-9_bib17","article-title":"A review of bioactive glasses: their structure, properties, fabrication, and apatite formation","author":"Kaur","year":"2013","journal-title":"J Biomed Mater Res A"},{"issue":"712","key":"10.1016\/B978-0-323-32889-0.00016-9_bib18","first-page":"1","article-title":"Effects of hydroxyapatite nanoparticles on proliferation and apoptosis of human breast cancer cells (MCF-7)","volume":"14","author":"Meena","year":"2012","journal-title":"J Nanopart Res"},{"issue":"3","key":"10.1016\/B978-0-323-32889-0.00016-9_bib19","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1098\/rsfs.2011.0121","article-title":"Mesoporous bioactive glasses: structure characteristics, drug\/growth factor delivery and bone regeneration application","volume":"2","author":"Wu","year":"2012","journal-title":"Interface Focus"},{"issue":"8","key":"10.1016\/B978-0-323-32889-0.00016-9_bib20","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1016\/j.actbio.2010.02.012","article-title":"Sol\u2013gel silica-based biomaterials and bone tissue regeneration","volume":"6","author":"Arcos","year":"2010","journal-title":"Acta Biomater"},{"key":"10.1016\/B978-0-323-32889-0.00016-9_bib21","unstructured":"Chen Q, Roether JA, Boccaccini AR. Tissue engineering scaffolds from bioactive glass and composite [internet]. In: Ashammakhi N, Reis R, Chiellini F, editors. Topics in tissue engineering, vol. 4. Available from: http:\/\/www.oulu.fi\/spareparts\/ebook_topics_in_t_e_vol4\/list_of_contr.html; 2008. p. 1\u201327 [Chapter 6]."},{"issue":"21","key":"10.1016\/B978-0-323-32889-0.00016-9_bib22","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1002\/smll.201000523","article-title":"Engineering nanocomposite materials for cancer therapy","volume":"6","author":"Minelli","year":"2010","journal-title":"Small"},{"issue":"3","key":"10.1016\/B978-0-323-32889-0.00016-9_bib23","doi-asserted-by":"crossref","first-page":"348","DOI":"10.4103\/0973-1482.103511","article-title":"Irradiation-mediated carbon nanotubes\u2019 use in cancer therapy","volume":"8","author":"Yu","year":"2012","journal-title":"J Cancer Res Ther"},{"key":"10.1016\/B978-0-323-32889-0.00016-9_bib24","doi-asserted-by":"crossref","first-page":"239","DOI":"10.4155\/tde.12.147","article-title":"Nanomedicine in chemoradiation","volume":"4","author":"Miller","year":"2013","journal-title":"Ther Deliv"},{"key":"10.1016\/B978-0-323-32889-0.00016-9_bib25","series-title":"Biomaterials science and engineering","article-title":"Biomaterials and biotechnology schemes utilizing TiO2 nanotube arrays","author":"Brammer","year":"2011"},{"issue":"2","key":"10.1016\/B978-0-323-32889-0.00016-9_bib26","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.colsurfb.2010.12.011","article-title":"Incorporation of carboxylation multiwalled carbon nanotubes into biodegradable poly(lactic-co-glycolic acid) for bone tissue engineering","volume":"83","author":"Lin","year":"2011","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"6","key":"10.1016\/B978-0-323-32889-0.00016-9_bib27","doi-asserted-by":"crossref","first-page":"605","DOI":"10.2217\/nnm.09.47","article-title":"Testing strategies for the safety of nanoparticles used in medical applications","volume":"4","author":"Dusinska","year":"2009","journal-title":"Nanomedicine"},{"key":"10.1016\/B978-0-323-32889-0.00016-9_bib28","doi-asserted-by":"crossref","DOI":"10.3109\/17435390.2013.816798","article-title":"Immunotoxicity and genotoxicity testing of PLGA-PEO nanoparticles in human blood cell model","author":"Tulinska","year":"2013","journal-title":"Nanotoxicology"},{"issue":"9\u201310","key":"10.1016\/B978-0-323-32889-0.00016-9_bib29","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1002\/smll.201201229","article-title":"Interfacing engineered nanoparticles with biological systems: anticipating adverse nano-bio interactions","volume":"9","author":"Pelaz","year":"2013","journal-title":"Small"},{"issue":"1","key":"10.1016\/B978-0-323-32889-0.00016-9_bib30","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.tiv.2013.06.009","article-title":"Genotoxicity evaluation of nanosized titanium dioxide, synthetic amorphous silica and multi-walled carbon nanotubes in human lymphocytes","volume":"28","author":"Tavares","year":"2014","journal-title":"Toxicol In Vitro"},{"issue":"3","key":"10.1016\/B978-0-323-32889-0.00016-9_bib31","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1021\/ar300031y","article-title":"Physicochemical properties determine nanomaterial cellular uptake, transport, and fate","volume":"46","author":"Zhu","year":"2012","journal-title":"Acc Chem Res"},{"issue":"8","key":"10.1016\/B978-0-323-32889-0.00016-9_bib32","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1021\/ja107583h","article-title":"Physical\u2013chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles","volume":"133","author":"Monopoli","year":"2011","journal-title":"J Am Chem Soc"},{"key":"10.1016\/B978-0-323-32889-0.00016-9_bib33","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3109\/17435390.2010.509519","article-title":"Physico-chemical features of engineered nanoparticles relevant to their toxicity","volume":"4","author":"Fubini","year":"2010","journal-title":"Nanotoxicology"},{"issue":"5","key":"10.1016\/B978-0-323-32889-0.00016-9_bib34","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/wnan.41","article-title":"Biopersistence and potential adverse health impacts of fibrous nanomaterials: what have we learned from asbestos?","volume":"1","author":"Sanchez","year":"2009","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"issue":"7","key":"10.1016\/B978-0-323-32889-0.00016-9_bib35","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1289\/ehp.7339","article-title":"Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles","volume":"13","author":"Oberd\u00f6rster","year":"2005","journal-title":"Environ Health Perspect"},{"key":"10.1016\/B978-0-323-32889-0.00016-9_bib36","series-title":"Nanotechnology Research Directions for societal needs in 2020, WTEC Panel Report","author":"Roco","year":"2010"},{"key":"10.1016\/B978-0-323-32889-0.00016-9_bib37","unstructured":"WHO\u2014World Health Organization. WHO human health risk assessment toolkit: chemical hazards, IPCS harmonization project document, no. 8. Ottawa, Canada; 2010."},{"key":"10.1016\/B978-0-323-32889-0.00016-9_bib38","first-page":"82","article-title":"European Parliament resolution of 24 April 2009 on regulatory aspects of nanomaterials (2008\/2208(INI))","volume":"C 184 E","author":"European Parliament","year":"2010","journal-title":"Official J Eur Union"},{"key":"10.1016\/B978-0-323-32889-0.00016-9_bib39","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1039\/c2nr11688j","article-title":"Health implications of engineered nanomaterials","volume":"4","author":"Pietroiusti","year":"2012","journal-title":"Nanoscale"},{"issue":"Suppl. 1","key":"10.1016\/B978-0-323-32889-0.00016-9_bib40","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1093\/toxsci\/kfq372","article-title":"The new toxicology of sophisticated materials: nanotoxicology and beyond","volume":"120","author":"Maynard","year":"2011","journal-title":"Toxicol Sci"},{"key":"10.1016\/B978-0-323-32889-0.00016-9_bib41","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3109\/17435390.2010.482751","article-title":"Possible genotoxic mechanisms of nanoparticles: criteria for improved test strategies","volume":"4","author":"Donaldson","year":"2010","journal-title":"Nanotoxicology"},{"issue":"2","key":"10.1016\/B978-0-323-32889-0.00016-9_bib42","first-page":"43","article-title":"Importance of Genotoxicity & S2A guidelines for genotoxicity testing for pharmaceuticals","volume":"1","author":"Shah","year":"2012","journal-title":"IOSR J Pharm Biol Sci"},{"key":"10.1016\/B978-0-323-32889-0.00016-9_bib43","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1016\/j.rmr.2011.09.008","article-title":"Respiratory effects of manufactured nanoparticles","volume":"28","author":"Andujar","year":"2011","journal-title":"Rev Mal Respir"},{"issue":"23\u201324","key":"10.1016\/B978-0-323-32889-0.00016-9_bib44","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1016\/j.biomaterials.2009.04.009","article-title":"Nanogenotoxicology: the DNA damaging potential of engineered nanomaterials","volume":"30","author":"Singh","year":"2009","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/B978-0-323-32889-0.00016-9_bib45","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s11671-009-9451-2","article-title":"Interaction between nano-anatase TiO(2) and liver DNA from mice in vivo","volume":"5","author":"Li","year":"2009","journal-title":"Nanoscale Res Lett"},{"issue":"1","key":"10.1016\/B978-0-323-32889-0.00016-9_bib46","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.yexcr.2004.12.021","article-title":"Formation of nucleoplasmic protein aggregates impairs nuclear function in response to SiO2 nanoparticles","volume":"305","author":"Chen","year":"2005","journal-title":"Exp Cell Res"},{"issue":"2","key":"10.1016\/B978-0-323-32889-0.00016-9_bib47","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1021\/nn800596w","article-title":"Cytotoxicity and genotoxicity of silver nanoparticles in human cells","volume":"3","author":"AshaRani","year":"2009","journal-title":"ACS Nano"},{"key":"10.1016\/B978-0-323-32889-0.00016-9_bib48","unstructured":"ICH\u2014International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. S2(R1) Genotoxicity Testing and Data Interpretation for Pharmaceuticals Intended for Human Use. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER) and Center for Biologics Evaluation and Research (CBER). Available from: http:\/\/www.fda.gov."},{"key":"10.1016\/B978-0-323-32889-0.00016-9_bib49","unstructured":"ICH\u2014International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use. S1(A) The Need for Long-term Rodent Carcinogenicity Studies of Pharmaceuticals. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER) and Center for Biologics Evaluation and Research (CBER). Available from: http:\/\/www.fda.gov; 1996."},{"key":"10.1016\/B978-0-323-32889-0.00016-9_bib50","unstructured":"EMEA\u2014European Medicines Agency. ICH Topic S1A-The Need for Carcinogenicity Studies of Pharmaceuticals, CPMP\/ICH\/140\/95. Available from: http:\/\/www.emea.eu.int; 1996."},{"key":"10.1016\/B978-0-323-32889-0.00016-9_bib51","unstructured":"EMEA\u2014European Medicines Agency. ICH Topic S1B-Carcinogenicity: Testing for Carcinogenicity of Pharmaceuticals. CPMP\/ICH\/299\/95. Available from: http:\/\/www.emea.eu.int; 1998."},{"key":"10.1016\/B978-0-323-32889-0.00016-9_bib52","unstructured":"EMEA\u2014European Medicines Agency ICH Topic S2 (R1): Guidance on Genotoxicity Testing and Data Interpretation for Pharmaceuticals Intended for Human Use. EMEA\/CHMP\/ICH\/126642\/2008. Available from: http:\/\/www.emea.eu.int; 2008."},{"issue":"3","key":"10.1016\/B978-0-323-32889-0.00016-9_bib53","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1073\/pnas.70.3.782","article-title":"An improved bacterial test system for the detection and classification of mutagens and carcinogens","volume":"70","author":"Ames","year":"1973","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1\u20132","key":"10.1016\/B978-0-323-32889-0.00016-9_bib54","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0027-5107(00)00064-6","article-title":"The Ames Salmonella\/microsome mutagenicity assay","volume":"455","author":"Mortelmans","year":"2000","journal-title":"Mutat Res"},{"issue":"2\u20133","key":"10.1016\/B978-0-323-32889-0.00016-9_bib55","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.mrrev.2008.10.002","article-title":"Genotoxicity investigations on nanomaterials: methods, preparation and characterization of test material, potential artifacts and limitations\u2014many questions, some answers","volume":"681","author":"Landsiedel","year":"2009","journal-title":"Mutat Res"},{"issue":"1\u20132","key":"10.1016\/B978-0-323-32889-0.00016-9_bib56","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.mrgentox.2011.09.013","article-title":"In vitro genotoxicity testing strategy for nanomaterials and the adaptation of current OECD guidelines","volume":"745","author":"Doak","year":"2012","journal-title":"Mutat Res"},{"issue":"2","key":"10.1016\/B978-0-323-32889-0.00016-9_bib57","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/em.20138","article-title":"Comparative analysis of the mutagenic activity of oxaliplatin and cisplatin in the Hprt gene of CHO cells","volume":"46","author":"Silva","year":"2005","journal-title":"Environ Mol Mutagen"},{"key":"10.1016\/B978-0-323-32889-0.00016-9_bib58","unstructured":"OECD\u2014Organisation for Economic Co-operation and Development. OECD Guidelines for the Testing of Chemicals: In vitro Mammalian Chromosome Aberration Test. Test No. 473; 1997."},{"key":"10.1016\/B978-0-323-32889-0.00016-9_bib59","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0027-5107(00)00065-8","article-title":"The in vitro micronucleus technique","volume":"455","author":"Fenech","year":"2000","journal-title":"Mutat Res"},{"key":"10.1016\/B978-0-323-32889-0.00016-9_bib60","unstructured":"OECD\u2014Organisation for Economic Co-operation and Development. OECD Guidelines for the Testing of Chemicals: In Vitro Mammalian Cell Micronucleus Test. Test No. 487; 2010."},{"issue":"1","key":"10.1016\/B978-0-323-32889-0.00016-9_bib61","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/aje\/kwj367","article-title":"Chromosomal aberrations and cancer risk: results of a cohort study from Central Europe","volume":"165","author":"Boffetta","year":"2007","journal-title":"Am J Epidemiol"},{"issue":"1","key":"10.1016\/B978-0-323-32889-0.00016-9_bib62","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/mutage\/geq075","article-title":"Micronuclei frequency in peripheral blood lymphocytes and cancer risk: evidence from human studies","volume":"26","author":"Bonassi","year":"2011","journal-title":"Mutagenesis"},{"key":"10.1016\/B978-0-323-32889-0.00016-9_bib63","unstructured":"OECD\u2014Organisation for Economic Co-operation and Development. OECD Guidelines for the testing of chemicals: Mammalian Erythrocyte Micronucleus Test. Test No. 474; 1997."},{"issue":"1","key":"10.1016\/B978-0-323-32889-0.00016-9_bib64","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/mutage\/geq085","article-title":"Reflections on the development of micronucleus assays","volume":"26","author":"Heddle","year":"2011","journal-title":"Mutagenesis"},{"issue":"11","key":"10.1016\/B978-0-323-32889-0.00016-9_bib65","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.2903\/j.efsa.2012.2977","article-title":"Minimum criteria for the acceptance of in vivo alkaline comet assay reports","volume":"10","author":"EFSA-European Food Safety Authority","year":"2012","journal-title":"EFSA J"},{"issue":"3","key":"10.1016\/B978-0-323-32889-0.00016-9_bib66","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J","article-title":"Single cell gel\/comet assay: guidelines for in vitro and in vivo genetic toxicology testing","volume":"35","author":"Tice","year":"2000","journal-title":"Environ Mol Mutagen"},{"issue":"1\u20132","key":"10.1016\/B978-0-323-32889-0.00016-9_bib67","first-page":"122","article-title":"DNA repair as a biomarker in human biomonitoring studies: further applications of the comet assay","volume":"736","author":"Collins","year":"2011","journal-title":"Mutat Res"},{"key":"10.1016\/B978-0-323-32889-0.00016-9_bib68","unstructured":"OECD\u2014Organisation for Economic Co-operation and Development. OECD Guidelines for the Testing of Chemicals: Transgenic Rodent Somatic and Germ Cell Gene Mutation Assays. Test No. 488; 2011."},{"issue":"2","key":"10.1016\/B978-0-323-32889-0.00016-9_bib69","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/toxsci\/kfr075","article-title":"Transgenic animal models in toxicology: historical perspectives and future outlook","volume":"121","author":"Boverhof","year":"2011","journal-title":"Toxicol Sci"},{"issue":"1\u20132","key":"10.1016\/B978-0-323-32889-0.00016-9_bib70","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.mrfmmm.2007.12.003","article-title":"Mutagenic effects of poly (ADP-ribose) polymerase-1 deficiency in transgenic mice","volume":"640","author":"Louro","year":"2008","journal-title":"Mutat Res"},{"key":"10.1016\/B978-0-323-32889-0.00016-9_bib71","doi-asserted-by":"crossref","DOI":"10.1002\/em.21864","article-title":"Integrated approach to the in vivo genotoxic effects of a titanium dioxide nanomaterial using LacZ plasmid-based transgenic mice","author":"Louro","year":"2014","journal-title":"Environ Mol Mutagen"},{"issue":"1","key":"10.1016\/B978-0-323-32889-0.00016-9_bib72","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/mutage\/geq088","article-title":"Adaptations of the in vitro MN assay for the genotoxicity assessment of nanomaterials","volume":"26","author":"Gonzalez","year":"2011","journal-title":"Mutagenesis"},{"key":"10.1016\/B978-0-323-32889-0.00016-9_bib73","unstructured":"OECD\u2014Organisation for Economic Co-operation and Development. Guidance on sample preparation and dosimetry for the safety testing of manufactured nanomaterials. Series on the Safety of Manufactured Nanomaterials, No. 36, ENV\/JM\/MONO(2012)40; 2012."},{"issue":"13\u201315","key":"10.1016\/B978-0-323-32889-0.00016-9_bib74","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1080\/15287394.2012.690326","article-title":"Can standard genotoxicity tests be applied to nanoparticles?","volume":"75","author":"Magdolenova","year":"2012","journal-title":"J Toxicol Environ Health A"},{"issue":"10","key":"10.1016\/B978-0-323-32889-0.00016-9_bib75","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.chemosphere.2010.09.022","article-title":"Genotoxicity of titanium dioxide (TiO2) nanoparticles at two trophic levels: plant and human lymphocytes","volume":"81","author":"Ghosh","year":"2010","journal-title":"Chemosphere"},{"issue":"1\u20132","key":"10.1016\/B978-0-323-32889-0.00016-9_bib76","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.mrgentox.2011.10.011","article-title":"Genotoxicity of inhaled nanosized TiO(2) in mice","volume":"745","author":"Lindberg","year":"2012","journal-title":"Mutat Res"},{"issue":"4","key":"10.1016\/B978-0-323-32889-0.00016-9_bib77","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/em.20615","article-title":"Nanosized titanium dioxide particles do not induce DNA damage in human peripheral blood lymphocytes","volume":"52","author":"Hackenberg","year":"2011","journal-title":"Environ Mol Mutagen"},{"issue":"7","key":"10.1016\/B978-0-323-32889-0.00016-9_bib78","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1080\/10408440903120975","article-title":"Development of in vitro systems for nanotoxicology: methodological considerations","volume":"39","author":"Stone","year":"2009","journal-title":"Crit Rev Toxicol"},{"key":"10.1016\/B978-0-323-32889-0.00016-9_bib79","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s00204-012-0838-y","article-title":"Genotoxicity investigations on nanomaterials","volume":"86","author":"Oesch","year":"2012","journal-title":"Arch Toxicol"},{"key":"10.1016\/B978-0-323-32889-0.00016-9_bib80","series-title":"Reference report by the JRC of the European Commission and a Policy Report by European Academies Science Advisory Council (EASAC)","article-title":"Impact of engineered nanomaterials on health: considerations for benefit-risk assessment","author":"Joint Research Centre and European Academies Science Advisory Council","year":"2011"},{"issue":"1\u20132","key":"10.1016\/B978-0-323-32889-0.00016-9_bib81","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.mrgentox.2012.06.012","article-title":"Genotoxicity testing of PLGA-PEO nanoparticles in TK6 cells by the comet assay and the cytokinesis-block micronucleus assay","volume":"748","author":"Kazimirova","year":"2012","journal-title":"Mutat Res"},{"key":"10.1016\/B978-0-323-32889-0.00016-9_bib82","unstructured":"Nanogenotox Joint Action. Facilitating the safety evaluation of manufactured nanomaterials by characterising their potential genotoxic hazard. Final Report:Paris. Available from: <www.nanogenotox.eu>; 2013."},{"key":"10.1016\/B978-0-323-32889-0.00016-9_bib83","first-page":"1805","article-title":"Toxicity and antibacterial assessment of chitosan-coated silver nanoparticles on human pathogens and macrophage cells","volume":"7","author":"Jena","year":"2012","journal-title":"Int J Nanomed"},{"issue":"2","key":"10.1016\/B978-0-323-32889-0.00016-9_bib84","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.mrgentox.2012.12.004","article-title":"Genotoxicity evaluation of stearic acid grafted chitosan oligosaccharide nanomicelles","volume":"751","author":"Hu","year":"2013","journal-title":"Mutat Res"},{"issue":"2","key":"10.1016\/B978-0-323-32889-0.00016-9_bib85","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.mrgentox.2009.12.016","article-title":"Acute toxicity and genotoxicity studies on poly(\u03b5-caprolactone)\u2013poly(ethylene glycol)\u2013poly(\u03b5-caprolactone) nanomaterials","volume":"696","author":"Huang","year":"2010","journal-title":"Mutat Res"},{"key":"10.1016\/B978-0-323-32889-0.00016-9_bib86","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s10924-010-0262-4","article-title":"Evaluation of cyto- and genotoxicity of poly(lactide-co-glycolide) nanoparticles","volume":"19","author":"Lima","year":"2011","journal-title":"J Polym Environ"},{"issue":"17","key":"10.1016\/B978-0-323-32889-0.00016-9_bib87","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1016\/S0142-9612(03)00132-7","article-title":"Assessment of genetic damage by methyl methacrylate employing in vitro mammalian test system","volume":"24","author":"Yang","year":"2003","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/B978-0-323-32889-0.00016-9_bib88","first-page":"314","article-title":"Genotoxicity effects of nano bioactive glass and Novabone bioglass on gingival fibroblasts using single cell gel electrophoresis (comet assay): an in vitro study","volume":"9","author":"Tavakoli","year":"2012","journal-title":"Dent Res J (Isfahan)"},{"key":"10.1016\/B978-0-323-32889-0.00016-9_bib89","first-page":"655","article-title":"Genotoxicity and cytotoxicity of nano hydroxyapatite and Algipore hydroxyapatite in periodontal fibroblasts cells","volume":"6","author":"Birang","year":"2011","journal-title":"J Isfahan Dent School"},{"key":"10.1016\/B978-0-323-32889-0.00016-9_bib90","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1109\/TNB.2012.2190418","article-title":"Effect of particle size of hydroxyapatite nanoparticles on its biocompatibility","volume":"11","author":"Ding","year":"2012","journal-title":"IEEE Trans Nanobiosci"},{"issue":"4","key":"10.1016\/B978-0-323-32889-0.00016-9_bib91","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/jat.2958","article-title":"Evaluation of cytotoxic, oxidative stress and genotoxic responses of hydroxyapatite nanoparticles on human blood cells","volume":"34","author":"Turkez","year":"2014","journal-title":"J Appl Toxicol"},{"key":"10.1016\/B978-0-323-32889-0.00016-9_bib92","first-page":"288","article-title":"In vitro and in vivo biocompatibility of nano-hydroxyapatite\/collagen composites","volume":"195","author":"Lin","year":"2005","journal-title":"Key Eng Mater"},{"issue":"1","key":"10.1016\/B978-0-323-32889-0.00016-9_bib93","doi-asserted-by":"crossref","first-page":"015105","DOI":"10.1088\/0957-4484\/24\/1\/015105","article-title":"Genotoxicity evaluation of dental restoration nanocomposite using comet assay and chromosome aberration test","volume":"24","author":"Musa","year":"2013","journal-title":"Nanotechnology"},{"issue":"3","key":"10.1016\/B978-0-323-32889-0.00016-9_bib94","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.msec.2012.12.033","article-title":"Study on the genotoxicity of HA\/ZrO2 composite particles in vitro","volume":"33","author":"Quan","year":"2013","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"10.1016\/B978-0-323-32889-0.00016-9_bib95","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ijbiomac.2013.04.011","article-title":"Evaluation of safety and efficacy of brain targeted chitosan nanoparticles of minocycline","volume":"59","author":"Nagpal","year":"2013","journal-title":"Int J Biol Macromol"},{"issue":"4","key":"10.1016\/B978-0-323-32889-0.00016-9_bib96","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3109\/02652048.2011.651500","article-title":"Poly(methyl methacrylate) particulate carriers in drug delivery","volume":"29","author":"Bettencourt","year":"2012","journal-title":"J Microencapsul"},{"issue":"1","key":"10.1016\/B978-0-323-32889-0.00016-9_bib97","doi-asserted-by":"crossref","DOI":"10.1088\/1468-6996\/14\/1\/015009","article-title":"In vitro and in vivo evaluation of electrospun PCL\/PMMA fibrous scaffolds for bone regeneration","volume":"14","author":"Son","year":"2013","journal-title":"Sci Technol Adv Mater"},{"key":"10.1016\/B978-0-323-32889-0.00016-9_bib98","unstructured":"WHO\u2014World Health Organization. Nanotechnology and human health: scientific evidence and risk governance. Report of the WHO expert meeting 10\u201311 December 2012 Bonn, Germany, Copenhagen, Denmark; 2013."},{"issue":"3","key":"10.1016\/B978-0-323-32889-0.00016-9_bib99","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1021\/ar300022h","article-title":"Nanomaterial toxicity testing in the 21st century: use of a predictive toxicological approach and high-throughput screening","volume":"46","author":"Nel","year":"2013","journal-title":"Acc Chem Res"},{"key":"10.1016\/B978-0-323-32889-0.00016-9_bib100","series-title":"Nanosafety in Europe 2015\u20132025: towards safe and sustainable nanomaterials and nanotechnology innovations","author":"Savolainen","year":"2013"},{"key":"10.1016\/B978-0-323-32889-0.00016-9_bib101","series-title":"Nanotechnology and human health: scientific evidence and risk governance","author":"WHO\u2014World Health Organization","year":"2013"}],"container-title":["Nanotechnology Applications for Tissue Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780323328890000169?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780323328890000169?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T03:51:35Z","timestamp":1537933895000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780323328890000169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"ISBN":["9780323328890"],"references-count":101,"URL":"https:\/\/doi.org\/10.1016\/b978-0-323-32889-0.00016-9","relation":{},"subject":[],"published":{"date-parts":[[2015]]}}}